• Home
  • About
    • Psilocybin (Magic Mushrooms)
    • Ayahuasca (Chacruna – Kaapi – Yajé)
    • MDMA (MDA – Sassafras)
    • Peyote Mescaline (Huachuma)
    • Kambo – Amazonian Frog
    • 5-MeO-DMT (Toad Medicine)
    • Rapé And Sacred Tobacco
    • Iboga (Ibogaine)
    • LSD (Lysergic Acid Diethylamide)
    • Cannabis (Marijuana)
    • Ketamine
    • Psychedelic Integration
    • Psychedelics Advocates
    • Frequently Asked Questions
    • Mental Health Symptoms
    • Substances Test Kits
    • Manifesto
    • Research Internship
  • Treatments
    • Latest Psychedelic Research
    • Addiction
    • Alcoholism
    • Anxiety
    • Bipolar Disorder
    • Cancer
    • Cluster Headaches
    • Depression
    • End Of Life
    • OCD
    • Neuropathy
    • Pain
    • Parkinson’s Disease
    • PTSD
    • Smoking
    • Help Treat Mental Illness
  • Microdosing
    • What is Microdosing?
    • Microdosing Magic Mushrooms
    • Microdosing LSD
    • Microdosing MDMA
    • Microdosing Ayahuasca
    • Microdosing Mescaline
    • Microdosing Cannabis
    • Microdosing Ibogaine
  • Resources
    • Past Events
    • ALL Locations
    • Ketamine Treatment
    • Medical Trials And Research
    • Psychedelic Research
    • EntheoPodcasts
    • In The News
    • Books On Psychedelics
    • Related Videos
    • EntheoResources
    • Terence McKenna
    • What Is Psychedelic Art?
    • Useful Links
    • Movies & Documentaries
    • Michael Pollan
Contact
  • Follow
  • Follow
  • Follow
  • Follow

Registration

Already have an account? Please login Here

IMPORTANT NOTICE:

This community is being designed as a secure space. It is not a place to seek, encourage, or participate in the procurement of controlled substances. Do not bring, buy, sell, transfer, or arrive on any illegal substances, or swap information on how to buy them. Attendees and/or members of this community who violate these basic house rules will be removed from the community and will not be allowed to attend future events.

Psychedelic Research

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity.

Aug 17, 2022

Marked increases in positive mood were produced by MDMA. Decreased CBF only was observed after MDMA, and this was localized to the right medial temporal lobe (MTL), thalamus, inferior visual cortex, and the somatosensory cortex. Decreased CBF in the right amygdala and...

The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favorite and worst autobiographical memories

Aug 17, 2022

Favorite memories were rated as significantly more vivid, emotionally intense and positive after MDMA than placebo and worst memories were rated as less negative. Functional MRI data from 17 participants showed robust activations to AMs in regions known to be involved...

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after MDMA psychotherapy: a prospective longterm follow-up study

Aug 17, 2022

Results for the 16 CAPS completers showed there were no statistical differences between mean CAPS score at LTFU (mean = 23.7; SD = 22.8) (tmatched = 0.1; df = 15, p = 0.91) and the mean CAPS score previously obtained at Study Exit (mean = 24.6, SD = 18.6). On average,...

Psychedelic Medicine

Pineal Gland and DMT (Dimethyltryptamine)

Sep 2, 2023

In the past few years, thrill-seekers from Hollywood, Silicon Valley and beyond have been travelling to South America to take part in so-called Ayahuasca retreats. Their goal: to partake in a brewed concoction made from a vine plant Banisteriopsis caapi, traditionally...

Psychedelic Use Statistics

Sep 2, 2023

With scientific progress marching on and psychedelic use among adults exploding, the need for creating infrastructure and delivering safe and legal access is already upon us. Recently published data from the annual Monitoring the Future (MTF) survey by the National...

Neuroplasticity Explained

Sep 2, 2023

A quarter of the world’s population is estimated to be affected by mental health or neurological challenges in their lifetime. In 2014, approximately 20% of U.S. adults had a mental illness and 22.5 million Americans aged 12 or older were in need of treatment for...

Mental Health Treatment Options

Sep 2, 2023

A quarter of the world’s population is estimated to be affected by mental health or neurological challenges in their lifetime. In 2014, approximately 20% of U.S. adults had a mental illness and 22.5 million Americans aged 12 or older were in need of treatment for...

Improving the End of Life Experience with Entheogens

Sep 2, 2023

:::In a 2019 study, 55% of families felt their loved one had a “bad death.” By igniting a movement to spark conversations and ask the right questions, we create opportunities for the things people most want – including spending time with those they love, dignity, and...

© 2023| All Rights Reserved, EntheoMedicine Community
  • Follow
  • Follow
  • Follow
  • Follow